90 related articles for article (PubMed ID: 12166896)
1. Expression of G2-M modulators in thyroid neoplasms: correlation of cyclin A, B1 and cdc2 with differentiation.
Ito Y; Yoshida H; Nakano K; Takamura Y; Kobayashi K; Yokozawa T; Matsuzuka F; Matsuura N; Kuma K; Miyauchi A
Pathol Res Pract; 2002; 198(6):397-402. PubMed ID: 12166896
[TBL] [Abstract][Full Text] [Related]
2. Cdc2 expression in primary thyroid lymphoma: its relationship with biological aggressiveness and G2 cyclins.
Ito Y; Yoshida H; Matsuzuka F; Matsuura N; Nakamura Y; Nakamine H; Kakudo K; Kuma K; Miyauchi A
Pathol Res Pract; 2003; 199(8):533-8. PubMed ID: 14533937
[TBL] [Abstract][Full Text] [Related]
3. Expression of the G2-M checkpoint regulators cyclin B1 and cdc2 in nonmalignant and malignant human breast lesions: immunocytochemical and quantitative image analyses.
Kawamoto H; Koizumi H; Uchikoshi T
Am J Pathol; 1997 Jan; 150(1):15-23. PubMed ID: 9006317
[TBL] [Abstract][Full Text] [Related]
4. Expression of the G2-M modulators in pancreatic adenocarcinoma.
Ito Y; Takeda T; Wakasa K; Tsujimoto M; Okada M; Matsuura N
Pancreatology; 2002; 2(2):138-45. PubMed ID: 12123094
[TBL] [Abstract][Full Text] [Related]
5. Expression and prognostic role of cyclin-dependent kinase 1 (cdc2) in hepatocellular carcinoma.
Ito Y; Takeda T; Sakon M; Monden M; Tsujimoto M; Matsuura N
Oncology; 2000 Jun; 59(1):68-74. PubMed ID: 10895070
[TBL] [Abstract][Full Text] [Related]
6. Association with Cdc2 and inhibition of Cdc2/Cyclin B1 kinase activity by the p53-regulated protein Gadd45.
Zhan Q; Antinore MJ; Wang XW; Carrier F; Smith ML; Harris CC; Fornace AJ
Oncogene; 1999 May; 18(18):2892-900. PubMed ID: 10362260
[TBL] [Abstract][Full Text] [Related]
7. Transient suppression of nuclear Cdc2 activity in response to ionizing radiation.
Kim MJ; Lee JY; Lee SJ
Oncol Rep; 2008 May; 19(5):1323-9. PubMed ID: 18425394
[TBL] [Abstract][Full Text] [Related]
8. Constitutive activation of cyclin B1-associated cdc2 kinase overrides p53-mediated G2-M arrest.
Park M; Chae HD; Yun J; Jung M; Kim YS; Kim SH; Han MH; Shin DY
Cancer Res; 2000 Feb; 60(3):542-5. PubMed ID: 10676633
[TBL] [Abstract][Full Text] [Related]
9. Immunohistochemical expression of cyclin D1, E2F-1, and Ki-67 in benign and malignant thyroid lesions.
Saiz AD; Olvera M; Rezk S; Florentine BA; McCourty A; Brynes RK
J Pathol; 2002 Oct; 198(2):157-62. PubMed ID: 12237874
[TBL] [Abstract][Full Text] [Related]
10. Decreased cyclin B1 expression contributes to G2 delay in human brain tumor cells after treatment with camptothecin.
Janss AJ; Maity A; Tang CB; Muschel RJ; McKenna WG; Sutton L; Phillips PC
Neuro Oncol; 2001 Jan; 3(1):11-21. PubMed ID: 11305412
[TBL] [Abstract][Full Text] [Related]
11. Expression of p27kip1 and Ki-67 in benign and malignant thyroid tumors.
Erickson LA; Jin L; Wollan PC; Thompson GB; van Heerden J; Lloyd RV
Mod Pathol; 1998 Feb; 11(2):169-74. PubMed ID: 9504687
[TBL] [Abstract][Full Text] [Related]
12. E2F-1 overexpression in U2OS cells increases cyclin B1 levels and cdc2 kinase activity and sensitizes cells to antimitotic agents.
Russo AJ; Magro PG; Hu Z; Li WW; Peters R; Mandola J; Banerjee D; Bertino JR
Cancer Res; 2006 Jul; 66(14):7253-60. PubMed ID: 16849574
[TBL] [Abstract][Full Text] [Related]
13. Loss of p57KIP2 is associated with colorectal carcinogenesis.
Li JQ; Wu F; Usuki H; Kubo A; Masaki T; Fujita J; Bandoh S; Saoo K; Takeuchi H; Kuriyama S; Ishida T; Imaida K
Int J Oncol; 2003 Dec; 23(6):1537-43. PubMed ID: 14612924
[TBL] [Abstract][Full Text] [Related]
14. Induced G2/M arrest and apoptosis in human epidermoid carcinoma cell lines by semisynthetic drug Ukrain.
Roublevskaia IN; Polevoda BV; Ludlow JW; Haake AR
Anticancer Res; 2000; 20(5A):3163-7. PubMed ID: 11062738
[TBL] [Abstract][Full Text] [Related]
15. Down-regulation of cyclin B1 and up-regulation of Wee1 by berberine promotes entry of leukemia cells into the G2/M-phase of the cell cycle.
Lin CC; Lin SY; Chung JG; Lin JP; Chen GW; Kao ST
Anticancer Res; 2006; 26(2A):1097-104. PubMed ID: 16619512
[TBL] [Abstract][Full Text] [Related]
16. Analysis of cyclin D1 and retinoblastoma protein immunoreactivity in follicular thyroid tumors.
Ferenc T; Lewiński A; Lange D; Niewiadomska H; Sygut J; Sporny S; Jarzab B; Satacińska-Los E; Kulig A; Włoch J
Pol J Pathol; 2005; 56(1):27-35. PubMed ID: 15921011
[TBL] [Abstract][Full Text] [Related]
17. Aberrant expression of cyclin A and cyclin B1 proteins in oral carcinoma.
Kushner J; Bradley G; Young B; Jordan RC
J Oral Pathol Med; 1999 Feb; 28(2):77-81. PubMed ID: 9950254
[TBL] [Abstract][Full Text] [Related]
18. Cyclin b1 promoter activity and functional cdk1 complex formation in G1 phase of human breast cancer cells.
Barrett KL; Demiranda D; Katula KS
Cell Biol Int; 2002; 26(1):19-28. PubMed ID: 11779217
[TBL] [Abstract][Full Text] [Related]
19. Physalis angulata induced G2/M phase arrest in human breast cancer cells.
Hsieh WT; Huang KY; Lin HY; Chung JG
Food Chem Toxicol; 2006 Jul; 44(7):974-83. PubMed ID: 16427178
[TBL] [Abstract][Full Text] [Related]
20. Iodine regulates G2/M progression induced by CCL21/CCR7 interaction in primary cultures of papillary thyroid cancer cells with RET/PTC expression.
Zhang YY; Liu ZB; Ye XG; Ren WM
Mol Med Rep; 2016 Oct; 14(4):3941-6. PubMed ID: 27574129
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
